1)   A transdermal treatment with MC903 ameliorates diet-induced obesity by reducing visceral fat and increasing myofiber thickness and energy consumption in mice.
Wada T, Miyazawa Y, Ikurumi M, Fuse K, Okekawa A, Onogi Y, Saito S, Tsuneki H, Sasaoka T.
Nutr Metab (Lond). 20:10, 2023.

2)   Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice.
Tsuneki H, Sugiyama M, Sato K, Ito H, Nagai S, Kon K, Wada T, Kobayashi N, Okada T, Toyooka N, Kawasaki M, Ito T, Otsubo R, Okuzaki D, Yasui T, Sasaoka T.
Eur J Pharmacol. 961:176190, 2023.

3)   Inhibition of adipose tissue angiogenesis prevents rebound weight gain after caloric restriction in mice fed a high-fat diet.
Lee HJ, Jin BY, Park MR, Kim NH, Seo KS, Jeong YT, Wada T, Lee JS, Choi SH, Kim DH.
Life Sci. 332:122101, 2023.

4)   Hachimijiogan, a traditional herbal medicine, modulates adipose cell function and ameliorates diet-induced obesity and insulin resistance in mice.
Kagawa S, Tanabe K, Hiromura M, Ogawa K, Koga T, Maeda T, Amo-Shiinoki K, Ochi H, Ichiki Y, Fukuyama S, Suzuki S, Suizu N, Ohmine T, Hamachi S, Tsuneki H, Okuya S, Sasaoka T, Tanizawa Y, Nagashima F.
Front Pharmacol. 14:1167934, 2023.